Steff Ascough

A brilliant day at our 'Diversity in immunology' event with @london-immuno.bsky.social 🧬

We explored the many layers of diversity, from immune responses to researcher perspectives, through inspiring talks, posters, and conversations #LIG25

Don’t miss future events: https://bit.ly/3v2aAi1

11.07.2025 15:00 — 👍 8    🔁 3    💬 0    📌 0

Intranasal monoclonal antibodies do not prevent respiratory infection in a randomized, controlled experimental infection trial Intramuscular monoclonal antibodies (mAbs) can prevent respiratory infections but are costly and not globally available. The development of intranasal mAbs offers a promising cost-reducing and non-inv...

Preprint of some fantastic, disruptive RSV CHIM research from our colleagues in Utrecht www.researchsquare.com/article/rs-5... Really showing the utility of experimental human challenges in drug discovery.

27.01.2025 10:00 — 👍 0    🔁 0    💬 0    📌 0

Fantastic 1st day at #RSVVW24 Conference in Mumbai. Really enjoyed the Mucosal Immunity session and the session Recognising the Impact of #RSV on Older Adults. Looking forward to an interesting week! #ReSViNET

14.02.2024 04:55 — 👍 0    🔁 0    💬 0    📌 0

Great work by respective lead authors Helen Wagstaffe (ICL) and Patrick Marsall (EKU Tübingen

13.02.2024 05:21 — 👍 0    🔁 0    💬 0    📌 0

Mucosal and systemic immune correlates of viral control after SARS-CoV-2 infection challenge in seronegative adults doi.org/10.1126/sciimm…
and
Development and validation of a respiratory syncytial virus multiplex immunoassay doi.org/10.1007/s15010 

13.02.2024 05:06 — 👍 0    🔁 0    💬 0    📌 0

Never had 2 papers published on the same day

13.02.2024 05:05 — 👍 1    🔁 0    💬 2    📌 0